atenolol has been researched along with Temporomandibular Disorders in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fávaro-Moreira, NC | 1 |
| Okoti, LW | 1 |
| Furini, R | 1 |
| Tambeli, CH | 2 |
| Oliveira-Fusaro, MC | 1 |
| Clemente-Napimoga, JT | 1 |
| Teixeira, JM | 1 |
| Torres-Chávez, KE | 1 |
| Parada, CA | 1 |
2 other studies available for atenolol and Temporomandibular Disorders
| Article | Year |
|---|---|
Gonadal hormones modulate the responsiveness to local β-blocker-induced antinociception in the temporomandibular joint of male and female rats.
Topics: Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Female; Gona | 2015 |
5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroi | 2012 |